Formulation for treatment of thromboembolism
AssigneeAstra Aktiebolag
InventorsJan-Erik Löfroth, Lennart Lindfors, Anna-Lena Ungell
Life of this patent
Estimating the term…
Abstract
A new pharmaceutical formulation comprising the thrombin inhibitor HOOC—CH2—(R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical formulation, the use of a such formulation in the treatment of thromboembolism as well as a method of treating a patient in need of such a treatment by using said formulation.
Claims25
A pharmaceutical formulation comprising the therapeutically active compound HOOC—CH2—(R)-Cgl-Aze-Pab or a physiologically acceptable salt thereof and one or more absorption enhancing agents selected from the group of a mono-, di- or triglyceride comprising at least one acyl group of chain length of 6 to 12 carbon atoms.
A mixture comprising the therapeutically active compound HOOC—CH2—(R)-Cgl-Aze-Pab or a physiologically acceptable salt thereof and one or more absorption enhancing agents selected from the group of a mono-, di- or triglyceride comprising at least one acyl group of chain length of 6 to 12 carbon atoms.
Dependencies are inferred from the claim text.